Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from OncoSil Medical Ltd ( (AU:OSL) ).
OncoSil Medical Ltd has announced its Annual General Meeting (AGM) scheduled for November 19, 2025, at K&L Gates in Melbourne. Shareholders are invited to participate in the meeting, with options to vote online or by proxy if unable to attend. This meeting is a significant event for stakeholders, providing an opportunity to discuss the company’s progress and future strategies.
The most recent analyst rating on (AU:OSL) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on OncoSil Medical Ltd stock, see the AU:OSL Stock Forecast page.
More about OncoSil Medical Ltd
OncoSil Medical Ltd operates in the medical industry, focusing on developing and commercializing innovative medical devices for the treatment of cancer. The company is primarily known for its OncoSil device, which is designed to deliver localized radiation therapy for pancreatic and liver cancer patients.
Average Trading Volume: 29,977
Technical Sentiment Signal: Sell
Current Market Cap: A$31.91M
For a thorough assessment of OSL stock, go to TipRanks’ Stock Analysis page.